Biotechnology company Thermo Fisher has announced plans to increase the impact of its growth strategy using artificial intelligence (AI) with OpenAI. Thermo Fisher believes the collaboration with OpenAI will help to improve the speed and success of drug development, enabling customers to get medicines to patients faster and more cost effectively. As part of the […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!